A company’s clinical trial app could reduce the time it takes for pharmaceutical companies and clinical research organizations to set up a site.
The app includes a global network of principal investigators grouped by country and by therapeutic area.
DrugDev presented the app as part of the Pfizer-sponsored entrepreneur pavilion at the DIA 2012 conference in Philadelphia this week.
The UK-based company has its U.S. offices in Princeton, New Jersey. Two of the co-founders have medical degrees and one is a CRO veteran.
It uses a network of more than 67,000 independently rated investigators to help clinical teams jump-start sites. By collecting relevant documents in each region in advance, clinical teams can routinely engage with potential investigators around protocol drafts, timelines, competitive studies and recruitment expectations long before a study is ready for launch, according to a company statement.
In a survey by DrugDev of 212 large- and midsized pharmaceutical companies and CROs, the average length of time it takes to set up a clinical trial site is three to four months, with many saying they would like to shorten that time. As part of its service, the company said it coordinates a monthly teleconference with investigators to update the drug developer or CRO on study progress.
But DrugDev might make more inroads with CROs than pharmaceutical companies, if a recent survey is any indicator, in which pharmaceutical companies would prefer to keep clinical trial investigator and site selection services in house.
Candice Yarde, DrugDev